NOTA:FRA
Novartis AG
145,00 €
0,00%
(0,00) 1D
16 nën, 8:05:42 p.d., GMT+1 · EUR
search
Të gjitha simbolet
| Me simbole | Çmimi | Ndrysho | % ndryshim |
|---|
insights_autoPo gjenerohen statistikat kryesore për NOTA...
Kapitalizimi i tregut
324,60 mld
Vëllimi mesatar
8,00
Vëllimi
0,00
Maksimumi 52-javor
146,00 €
Minimumi 52-javor
105,50 €
Numri i punonjësve
75 mijë
Kapitalizimi i tregut
324,60 mld
Vëllimi mesatar
8,00
Vëllimi
0,00
Maksimumi 52-javor
146,00 €
Minimumi 52-javor
105,50 €
Numri i punonjësve
75 mijë
Lajmet
Nga burimet në ueb dhe partnerët e lajmeve
Investing.com
·
3 orë më parë
Novartis wins FDA approval for Cosentyx in polymyalgia rheumatica
Yahoo Finance
·
3 orë më parë
Novartis Cosentyx® becomes first and only FDA-approved anti-IL-17 biologic for people with polymyalgia rheumatica (PMR)
Yahoo Finance
·
9 orë më parë
How Investors Are Reacting To Novartis (SWX:NOVN) Drug Approval Progress
Yahoo Finance
·
17 orë më parë
Is Novartis (NVS) Outperforming Other Medical Stocks This Year?
Profili
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz. Wikipedia
Rreth Novartis AG
Drejtori ekzekutivVasant Narasimhan
Punonjësit75,3 mijë
Themeluar më7 mar 1996
SeliaBasel, Basel City, Zvicër
SektoriHealth Care
Industria-
Uebsajtinovartis.com